title: Should women with diabetic nephropathy considering pregnancy continue ACE inhibitor or angiotensin II receptor blocker therapy until pregnancy is confirmed? Reply to Lewis G and Maxwell AP [letter].
authors: Institute of Health & Society, Newcastle University, Baddiley-Clark Building, Richardson Road, Newcastle upon Tyne, NE2 4AX, UK, peter.tennant@ncl.ac.uk.
authors: Peter W G
authors: PW
authors: Tennant
authors: Svetlana V
authors: SV
authors: Glinianaia
authors: Rudy W
authors: RW
authors: Bilous
authors: Judith
authors: J
authors: Rankin
authors: Ruth
authors: R
authors: Bell
mesh_terms: D000013:Congenital Abnormalities / Q000453:epidemiology*; D003922:Diabetes Mellitus, Type 1 / Q000150:complications*; D003924:Diabetes Mellitus, Type 2 / Q000150:complications*; D005260:Female; D005313:Fetal Death / Q000453:epidemiology*; D006801:Humans; D016742:Preconception Care / Q000379:methods*; D011247:Pregnancy; D011254:Pregnancy in Diabetics; D050497:Stillbirth / Q000453:epidemiology*